JP2011507860A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507860A5
JP2011507860A5 JP2010539517A JP2010539517A JP2011507860A5 JP 2011507860 A5 JP2011507860 A5 JP 2011507860A5 JP 2010539517 A JP2010539517 A JP 2010539517A JP 2010539517 A JP2010539517 A JP 2010539517A JP 2011507860 A5 JP2011507860 A5 JP 2011507860A5
Authority
JP
Japan
Prior art keywords
connexin
composition
polynucleotide
medicament
scar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014025 external-priority patent/WO2009085274A2/en
Publication of JP2011507860A publication Critical patent/JP2011507860A/ja
Publication of JP2011507860A5 publication Critical patent/JP2011507860A5/ja
Pending legal-status Critical Current

Links

JP2010539517A 2007-12-21 2008-12-22 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用 Pending JP2011507860A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US883707P 2007-12-21 2007-12-21
PCT/US2008/014025 WO2009085274A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014248303A Division JP2015057430A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用

Publications (2)

Publication Number Publication Date
JP2011507860A JP2011507860A (ja) 2011-03-10
JP2011507860A5 true JP2011507860A5 (enExample) 2013-04-25

Family

ID=40824958

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539517A Pending JP2011507860A (ja) 2007-12-21 2008-12-22 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
JP2014248303A Pending JP2015057430A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014248303A Pending JP2015057430A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用

Country Status (7)

Country Link
US (1) US20130184220A1 (enExample)
EP (1) EP2252320A2 (enExample)
JP (2) JP2011507860A (enExample)
AU (1) AU2008343755A1 (enExample)
CA (1) CA2710232A1 (enExample)
WO (1) WO2009085274A2 (enExample)
ZA (1) ZA201005221B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101573131B (zh) 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用
PT2049123E (pt) 2006-08-03 2013-03-06 Horizon Pharma Ag Tratamento de doença reumatóide com glucocorticóide de libertação retardada
CA2710380A1 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin 43 poly nucleotide for the treatment of fibrotic conditions
US9999702B2 (en) * 2010-04-09 2018-06-19 Kci Licensing Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
MX351881B (es) 2012-03-01 2017-11-01 Firststring Res Inc Geles tópicos que contienen péptidos de alfa-conexina c- terminal (act).
WO2015019124A1 (en) * 2013-08-05 2015-02-12 Societe De Developpement Et De Recherche Industrielle Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
JP6360332B2 (ja) 2014-03-20 2018-07-18 テルモ株式会社 送液ポンプ
WO2016029191A2 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
CN107106544B (zh) 2014-09-19 2021-09-24 纪念斯隆-凯特琳癌症中心 用于治疗脑转移瘤的方法
JP6716841B2 (ja) * 2016-02-10 2020-07-01 株式会社アルチザンラボ 止血材
WO2017192620A2 (en) * 2016-05-03 2017-11-09 University Of Auckland Novel peptides and peptidomimetics
CN111201247A (zh) 2017-04-28 2020-05-26 奥克兰联合服务有限公司 治疗方法和新颖构建体
CN110997018A (zh) * 2017-08-01 2020-04-10 医疗发明株式会社 止血材料及含有其的创伤敷料
EP3675874B1 (en) * 2017-09-01 2023-11-29 Excel Med, LLC Pharmaceuticals composition for treating keloid and uses thereof
JP7393780B2 (ja) * 2019-08-19 2023-12-07 学校法人順天堂 ギャップ結合機能制御剤のスクリーニング方法
US12667586B2 (en) 2023-03-07 2026-06-30 Glaukos Corporation Treatments for ocular surface disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
US7098190B1 (en) * 1999-01-27 2006-08-29 Coda Therapeutics Ltd. Formulations comprising antisense nucleotides to connexins
DE602004013439T2 (de) * 2003-06-09 2009-06-04 Ascend Therapeutics, Inc. Behandlung und prävention von übermässiger narbenbildung mit 4-hydroxy tamoxifen
JP5097891B2 (ja) * 2005-09-20 2012-12-12 株式会社ポーラファルマ 皮膚外用剤
RU2542471C2 (ru) * 2006-11-15 2015-02-20 Коуда Терапьютикс, Инк. Улучшенные способы и композиции для заживления ран
CN102920996A (zh) * 2007-12-11 2013-02-13 科达治疗公司 受损伤口愈合的药物组合物

Similar Documents

Publication Publication Date Title
JP2011506447A5 (enExample)
JP2011507861A5 (enExample)
JP2011507855A5 (enExample)
JP2011508605A5 (enExample)
JP2025128190A5 (enExample)
AU2003287423B2 (en) Methods and systems for enabling and stabilizing tooth movement
JP2023123756A5 (enExample)
RU2009122370A (ru) Улучшенные способы и композиции для заживления ран
US20050186526A1 (en) Methods and systems for enabling and stabilizing tooth movement
US20150343013A1 (en) Methods of treating neuropathic pain
Thiede et al. Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica)
JP2015057430A (ja) 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
JP2006515351A5 (enExample)
SI2999785T1 (en) SERPINA1 IRNA assemblies and procedures for their use
JP2007537288A5 (enExample)
JP2011507862A5 (enExample)
JP2020524129A (ja) 再発膠芽腫(rgbm)の治療方法
JP2011507857A5 (enExample)
JP2015083606A (ja) 線維症性の状態の治療のための抗コネキシンポリヌクレオチド剤と組み合わせた抗コネキシンポリペプチド剤の使用
JP2021510174A5 (enExample)
JP2009544585A5 (enExample)
Li et al. Role of paraventricular angiotensin AT1 receptors in salt-sensitive hypertension in mRen-2 transgenic rats
CN101896190A (zh) 用α胸腺肽和抗细胞毒性T淋巴细胞相关抗原4(CTLA4)的抗体的组合治疗黑素瘤
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
US11951178B2 (en) Methods for treating subjects suffering from acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles